Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05257538 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FMT in Initial CDI

Study acronym: FinCDI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2024 to Feb 28, 2027
    • Study completion date: Dec 30, 2026 to Feb 28, 2028
    • Collaborators revised (3)
    v3
  2. Collaborators revised (3)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.
Trial Details
NCT Number NCT05257538
Lead Sponsor Turku University Hospital
Collaborators: Satakunta Central Hospital, Helsinki University Central Hospital, PaijatHame Central Hospital
Conditions
(from sponsor)		 Clostridioides Difficile Infection
Related terms Clostridium Infections
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov